The phase 3 PhALLCON trial showed a trend toward improved EFS in patients with Ph+ newly diagnosed ALL when treated with ponatinib compared with imatinib.
A review of the importance family, friends, and a support system have on the cancer journey and survival outcomes for young adults with cancer.
At EAHAD 2023, researchers reported positive results from trials of patients with hemophilia A and B, including those who are difficult to treat.
High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.
Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.
Addressing moral distress means not just obtaining ethics consultation as needed but also dealing with the feeling of powerlessness that often accompanies it.
Researchers sought to determine whether there were delays in or discontinuation of treatment for cancer among different populations during the COVID-19 pandemic.
The FBI and other federal agencies have issued warnings about a ransomware and data extortion group called the Daixin Team.
Researchers are conducting phase 2 and 3 trials to investigate novel treatment combinations for patients with DLBCL.
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.
Researchers sought to address the variability in definitions for key outcomes in trials involving pediatric ALL.
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Nurse practitioner experiences poor provider etiquette when making medical decisions for her father who was hospitalized following COVID-19 infection.
Climate change has already damaged human health, food supplies, and the environment. Rapid, decisive, coordinated action is needed to avert catastrophic health impacts.
The number of US health care providers certified to prescribe buprenorphine more than doubled in the past 4 years, and treatment advocates hope to see that trend continue.
A review of the relationship between cancer, pain, pain management, and radiotherapy.
Research in patients with CLL showed that zanubrutinib can outperform ibrutinib, a triplet is effective for high-risk CLL, cell death may predict the depth of response, and a CAR T-cell therapy is likely not an option for CLL patients.
Results from the MEDALIST, ASCERTAIN, STIMULUS-MDS1, and SINTRA-REV trials may help inform the treatment of MDS.
At a SITC summit, stakeholders identified administrative, staffing, and other barriers that impede progress in clinical cancer research.
Author discusses her experiences with microaggressions in the workplace and calls for sustained efforts to enact change.
Prior to the introduction of CAR T-cell therapy, pediatric patients with ALL had limited treatment options for relapsed or refractory disease.
As the pandemic unfolded, the health care industry was forced to lean on community pharmacies.
This review describes specialized programs for adolescent and young adults with cancer and the process undertaken by a US facility to develop its program.
Researchers sought to determine the landscape of BTK inhibitors for treating patients with CLL.
HIPAA protects patients from unauthorized disclosure of personal information by covered entities such as medical practices and hospitals, but out from under the HIPAA umbrella, patients are mostly on their own, according to the authors of a recent report.
This review article discusses how cancer care may cause survivors of sexual trauma to re-experience their trauma and offers tips on how to mitigate this potential.
The SAFER program is helping Ukrainian children with cancers and other blood disorders to continue their therapy in Ukraine at centers in Europe and North America.
Ethics consultants begin by identifying and clarifying the conflict to ensure it is related to ethics.
Data suggest that most patients who use medical aid in dying (MAID) have cancer, but some oncology providers do not feel well informed about MAID.
Researchers sought to determine whether the JAK/STAT pathway would be actionable for the treatment of patients with B-ALL.
Surrogate decision makers for a patient are obligated to make health care decisions based on what the patient would have wanted if it is known.
Expert provides strategies for advocating for APRN full practice authority by presenting the health equity case and business case.
Acupuncture and moxibustion, which are sometimes used together, have shown promise in reducing insomnia in patients with cancer.
New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
Changes to abortion laws in the US could have unintended consequences for cancer patients and others seeking fertility preservation.
Researchers sought to determine how to address barriers to access to gene therapy for patients with thalassemia.
Experts discuss current and potential future shortages affecting the oncology field as well as strategies for preventing and managing shortages.
In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.
A growing body of research suggests that patients are not always transparent with their physicians about critical information.
Researchers sought to determine the effectiveness of using electronic health record prompts to assess patients for smoking, desire to quit, and access to smoking cessation programs.
Clinicians need to be aware of their assumptions about patients based on age.
Researchers sought to determine any disparities in diversity among stem cell transplant physicians and leadership in the United States.
Research has revealed patterns of opioid use and misuse in cancer patients and survivors.
Implicit bias among health care providers factors into judgments and influences clinical decision making.
Dr Jeffery J. Auletta, from NMDP/Be The Match, reviews data on mismatched unrelated donor transplants in a diverse population of patients with hematologic malignancies.
Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.
Military hospitals are implementing therapy dog programs to support patients, families, and staff.
Researchers sought to determine the incidence, nature, and consequences of oncologists’ experiences with workplace sexual harassment.